Delivery Order SPE2DR25D3005-SPE2DR26FP8BF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $5,337.74. This firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively made with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,244.20 on December 1, 2025, for the supply of Multaq 400 mg tablets (60 count). This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 2, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement executed under the company's existing contract vehicle with DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $2,962.26. This is a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $11,985.90. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $5,016.52 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Multaq 400 mg tablets (60-count units). This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with a completion date of December 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,290.92 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on December 3, 2025, with a completion date of December 4, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a contract value of $2,807.91. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract is scheduled for ultimate completion by December 11,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Multaq 400 mg tablets (60 count). This is a firm fixed-price delivery order with a ceiling value of $2,172.55, with an ultimate completion date of December 9, 2025. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the company's ability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract valued at $3,087.71. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of November 25, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $12,728.18. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract is scheduled for completion by November 28, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8BFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $17,731.53. This non-set-aside award is classified as a delivery order with an ultimate completion date of December 16, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities. The contract award reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements through competitive acquisition and its integral role in supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 12/14/25 |